Get started
Author

Stefan Knop

Observed name: Knop, Stefan
ORCID: 0000-0003-1276-6639
Observed ORCID: 0000-0003-1276-6639
OpenAlex ID: A5135587709
Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis
2026 · Efstathios Kastritis, Giovanni Palladini, et al. · Blood · 27
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
2026 · Martin Wermke, Sebastian Ochsenreither, et al. · Nature Medicine · 8
PDF
Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis
2026 · Nico Gagelmann, Hermann Einsele, et al. · Journal of Hematology & Oncology · 5
Infectious toxicities associated with bispecific antibodies and CAR-T Cells in multiple myeloma: a systematic review
2026 · Magdalena Benda, Patrick Reimann, et al. · Annals of Hematology · 4
Epcoritamab in Richter transformation: insights from a real-world case series
2026 · Vanja Zeremski, Sina A. Beer, et al. · Blood Advances · 1
PDF
Comorbidity management in inflammatory rheumatic diseases: a dual-perspective survey of patients and rheumatologists
2026 · Vanessa Bartsch, Basel Habboub, et al. · Arthritis Research & Therapy
PDF
Additional file 1 of Comorbidity management in inflammatory rheumatic diseases: a dual-perspective survey of patients and rheumatologists
2026 · Vanessa Bartsch, Basel Habboub, et al. · Figshare
Renal rescue in myeloma: How deep does the hematologic response need to be?
2026 · Friederike Bachmann, Stefan Knop · Med
Early deep response to cilta-cel as 2nd CAR T-Cell therapy after CELMoD-based bridging for advanced multiple myeloma
2026 · Henrik Niklas, Anna Bold, et al. · Annals of Hematology
PDF
Integrated Psychosomatic Care in General Hospital Medicine: An Observational Study of Outcomes in Medically Complex Inpatients
2026 · Paul Köbler, Hanna Hofmann, et al. · Journal of the Academy of Consultation-Liaison Psychiatry
First-in-human results with IMA401, a MAGEA4/8-targeted T-cell receptor–based bispecific T-cell engager (TCER) in recurrent or refractory solid tumors.
2026 · Martin Wermke, Dirk Jaeger, et al. · Journal of Clinical Oncology
Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis
2026 · Nico Gagelmann, Hermann Einsele, et al. · Figshare
Additional file 1 of Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis
2026 · Nico Gagelmann, Hermann Einsele, et al. · Figshare
Morbus Castleman
2026 · Schweizerische Gesellschaft für Hämatologie, Hoffmann, Christian, et al. · PUBLISSO (German National Library of Medicine)
Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis
2026 · Gagelmann, Nico, Einsele, Hermann, et al. · Fraunhofer-Publica (Fraunhofer-Gesellschaft)
Up front allogeneic stem cell transplant is superior to tandem high-dose melphalan in cytogenetically defined ultra high-risk myeloma
2011 · Knop, Stefan, Liebisch, Peter, et al. · GRO
Phase II study of radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced-intensity conditioning regimen for allogeneic haematopoietic cell transplantation in patients with advanced indolent non-Hodgkin lymphoma
2010 · Bethge, Wolfgang A., Lange, T., et al. · GRO
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced-intensity conditioning regimen for allogeneic haematopoietic cell transplantation in patients with advanced indolent non-Hodgkin's lymphoma
2009 · Bethge, Wolfgang A., Lange, T., et al. · GRO
Total Marrow Irradiation, Busulfan, and Cyclophosphamide Is Equivalent to Tandem Melphalan in Myeloma
2009 · Knop, Stefan, Neveling, K., et al. · GRO
Works count: 21
Citation count: 45
H-index: 4
I10-index: 1
Year
Topic
Type